Sascha Tuchman is a Hematologist and an Oncologist in Chapel Hill, North Carolina. Dr. Tuchman is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). His top areas of expertise are Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Tuchman is currently accepting new patients.

Murat Arcasoy is a Hematologist Oncology specialist and a Hematologist in Durham, North Carolina. Dr. Arcasoy is rated as a Distinguished provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). His top areas of expertise are Essential Thrombocythemia, Polycythemia Vera, Myelofibrosis, Monoclonal Gammopathy of Undetermined Significance (MGUS), and Bone Marrow Aspiration. Dr. Arcasoy is currently accepting new patients.

Brandi Reeves is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Reeves is rated as an Advanced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). Her top areas of expertise are Multiple Myeloma, Polycythemia Vera, Essential Thrombocythemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Reeves is currently accepting new patients.

Katarzyna Jamieson is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Jamieson is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). Her top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Jamieson is currently accepting new patients.

Matthew Painschab is a Hematologist and an Oncologist in Chapel Hill, North Carolina. Dr. Painschab is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). His top areas of expertise are Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, Non-Hodgkin Lymphoma, Multicentric Castleman Disease (MCD), and Bone Marrow Aspiration.

Samuel Rubinstein is a Hematologist and an Oncologist in Chapel Hill, North Carolina. Dr. Rubinstein is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Primary Amyloidosis, and Bone Marrow Aspiration. Dr. Rubinstein is currently accepting new patients.

Jonathan Serody is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Serody is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). His top areas of expertise are Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Serody is currently accepting new patients.

Alicia Pinto is a Nurse Practitioner specialist and a Hematologist Oncology provider in Chapel Hill, North Carolina. Ms. Pinto is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). Her top areas of expertise are Acute Myeloblastic Leukemia with Maturation, Acute Myeloblastic Leukemia without Maturation, Acute Myeloid Leukemia (AML), and Childhood Acute Myeloid Leukemia.

Hendrik Vandeventer is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Vandeventer is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). His top areas of expertise are Chronic Lymphocytic Leukemia (CLL), Aplastic Anemia, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration. Dr. Vandeventer is currently accepting new patients.

William Wood is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Wood is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). His top areas of expertise are Multiple Myeloma, Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Wood is currently accepting new patients.

Paul Armistead is a Hematologist Oncology specialist and a Hematologist in Chapel Hill, North Carolina. Dr. Armistead is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). His top areas of expertise are Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Multiple Myeloma, Myelodysplastic Syndrome (MDS), and Bone Marrow Transplant. Dr. Armistead is currently accepting new patients.

Daniel Richardson is a Hematologist and an Oncologist in Chapel Hill, North Carolina. Dr. Richardson is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). His top areas of expertise are Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Chronic Myelomonocytic Leukemia (CMML), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration. Dr. Richardson is currently accepting new patients.

Thomas Shea is a Hematologist Oncology provider in Chapel Hill, North Carolina. Dr. Shea is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). His top areas of expertise are Non-Hodgkin Lymphoma, Multiple Myeloma, Hodgkin Lymphoma, Bone Marrow Transplant, and Bone Marrow Aspiration.

I study disorders of the bone marrow and bone marrow failure syndromes. I also see some leukemias and lymphomas and other blood malignancies. Duke offers a very personalized, individualized level of care to each patient. Nobody is the same, so we take the whole patient, we listen to them, and we offer our best recommendations for treatment options. We offer some of the latest treatment options that are available, usually in the setting of a clinical trial. If not, we offer the latest advancement in the field. When I was going through medical school, molecular biology was the new field. Everything was being described as a new cancer-causing gene. And to me that was so appealing – we’re going to figure out what causes cancer and new ways to treat it. That’s what really brought me into the hematology oncology world – things were being discovered that were new and exciting and hopefully would lead to new treatment options. Duke offers an extremely high standard of care. Though we’re not always successful and the disease sometimes wins, our goal is to give the patients the best possible care. Dr. Decastro is rated as an Advanced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). His top areas of expertise are Paroxysmal Nocturnal Hemoglobinuria (PNH), Aplastic Anemia, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Aspiration.

Since studying basic immunology prior to beginning my clinical training, I have been deeply interested in applying immunological perspective for the treatment of cancers including hematologic malignancies. Interestingly emerging immunotherapies showed very promising results in recent years. In my clinic, I treat patients with multiple myeloma which is one type of cancer arising from plasma cells. My research will focus on developing early phase clinical protocols utilizing novel cellular therapy approach and also improving the outcomes of blood and marrow transplantation. My ultimate goal is to provide better treatment options than the current standard approach to patients. Dr. Choi is rated as an Advanced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). His top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Bone Marrow Transplant, and Bone Marrow Aspiration.

What makes Duke Health unique in bone marrow transplants is its holistic approach. We take care of the disease -- which is important, because these are very serious, potentially fatal diseases. But at the same time, we pay attention to patients’ emotional and psychological well-being in addition to their physical well-being. And not only for patients but also the whole family, because the caregivers and other parts of the family need attention as well. I wanted to go into medicine, because it was a great way to interact and take care of patients. In my mind, cancer is one of two diseases within internal medicine where you can actually cure people. The best part of bone marrow transplant is that the time between the laboratory and the patient is short. Patients who need a transplant tend to be relatively sick and in need of new therapies. That’s been very intellectually challenging and fun. Dr. Chao is rated as an Advanced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). His top areas of expertise are Graft Versus Host Disease (GvHD), Chronic Graft Versus Host Disease (cGvHD), Multiple Myeloma, Bone Marrow Transplant, and Bone Graft.

People in need of a bone marrow transplantation can often be scared or intimidated by what is ahead of them -- my goal, when seeing a new patient, is to devote all the time and effort that is needed to address these emotions. My hope is that after this visit, my patient will feel reassured and hopeful that the Duke team of providers will do all that it can to restore them to health, and allow them to return to their lives. Dr. Horwitz is rated as an Advanced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). His top areas of expertise are Chronic Graft Versus Host Disease (cGvHD), Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Bone Marrow Transplant, and Bone Marrow Aspiration.

The Division of Cellular Therapy does bone marrow transplants and stem cell transplants for patients with different types of blood cancers. Specifically, I see patients with multiple myeloma or other plasma cell issues like amyloidosis. Many of the cases in my clinic are difficult. So I spend a lot of time talking with my patients, explaining the disease when they come as new patients and talking about the complexity of the disease, because it’s important that they understand what to ask their physicians here at Duke and at home. There’s no standard treatment for myeloma. We have different options – continuation of therapy, immediate transplant or transplant later. I like to explain to patients why I favor a certain treatment approach and why I think it would be the best approach for them. Dr. Gasparetto is rated as an Advanced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). Her top areas of expertise are Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Colonoscopy.

I primarily see patients who have a variety of rare bleeding and clotting disorders. I see both older and younger patients and also provide help when patients need to transition to and away from blood thinners. Doctors usually refer patients to me. I try to work with each patient so they understand why they are seeing me and what is going on with their body. I enjoy when a patient can leave my office with a complete understanding of what is going on and what they need to do to get better. As a young child, I had bad allergies and spent much time in the doctor’s office. As a frequent patient, I enjoyed spending time around medicine. As I entered college, I found that I enjoyed chemistry and that hematology allowed me to combine lab work with patient care. Dr. Ortel is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). His top areas of expertise are Venous Thromboembolism (VTE), Antiphospholipid Syndrome, Thrombocytopenia, Deep Vein Thrombosis, and Thalamotomy.

Gowthami Arepally is a Hematologist in Durham, North Carolina. Dr. Arepally has been practicing medicine for over 36 years and is rated as an Experienced provider by MediFind in the treatment of Multicentric Castleman Disease (MCD). Her top areas of expertise are Thrombocytopenia, Adult Immune Thrombocytopenia, Sickle Cell Disease, and Immune Thrombocytopenic Purpura (ITP).